Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter

João Mesquita1, António Miguel Ferreira1,2, Diogo Cavaco1,2

  • 1Cardiology Department, Hospital de Santa Cruz, Av. Prof. Reinaldo dos Santos, Carnaxide, Lisbon, Portugal.

Insights

A new risk score helps predict atrial fibrillation (AF) recurrence after catheter ablation. This tool identifies patients at high risk for AF relapse post-pulmonary vein isolation (PVI).

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Informatics

Background:

  • Catheter ablation for atrial fibrillation (AF) is common, but predicting relapse remains difficult.
  • Existing methods for assessing individual patient risk of AF recurrence post-ablation are insufficient.

Purpose of the Study:

  • To develop and validate a novel risk score for estimating AF recurrence after the first radiofrequency pulmonary vein isolation (PVI).

Main Methods:

  • A retrospective analysis of 1934 patients undergoing their first PVI was performed.
  • A risk score was developed using Cox regression in 50% of patients and validated in the other 50%.
  • Predictors included age, sex, AF type, smoking status, and left atrial volume.

Main Results:

  • Five independent predictors were identified: age >60, female sex, non-paroxysmal AF, current smoking, and indexed left atrial volume.
  • The score demonstrated good discriminative power (c-statistic 0.75) in both development and validation cohorts.
  • AF recurrence rates per year were 8% (low-risk), 11% (intermediate-risk), and 17-18% (high-risk).

Conclusions:

  • A validated, simple risk score effectively estimates AF recurrence risk after PVI.
  • The score can aid in patient selection and risk stratification for AF ablation procedures.
  • Further external validation is recommended to assess its utility as a patient selection tool.
Abstract